Phytotherapy · Venous & Circulatory Support · Sapindaceae

Horse Chestnut

Aesculus hippocastanum L. (Sapindaceae) — the large ornamental tree from Asia Minor whose seed holds escin, the saponin behind its venotonic, anti-edematous and anti-inflammatory effects. Its seed extract is the most studied herbal remedy for chronic venous insufficiency, and it carries real precautions for the kidneys and for anticoagulant users.

20 Primary Refs
12 Properties
Seed Parts Used
✦ Researched
Last Updated October 25, 2026
Primary Source Wikiphyto · NCBI PubMed · Cochrane Review
Family Sapindaceae
Large Ornamental Tree · Asia Minor

Botanical Overview

Horse chestnut is a large ornamental tree native to Asia Minor and northern Greece, not India despite its French name. It has long-stalked palmate compound leaves and fragrant flowers in pyramidal panicles, with white petals spotted pink. The fruit is a spiny capsule.

HabitLarge tree
OriginAsia Minor, N. Greece
FlowersWhite, pink-spotted
FruitSpiny capsule
Taxonomic Classification

Taxonomy & Identification

Latin Name
Aesculus hippocastanum L.
Family
Sapindaceae (APG III, 2009); the name Hippocastanaceae is no longer valid
Common Names
Horse Chestnut, Marronnier d'Inde, Marron d'Inde
Parts Used
Seed; stem bark also in the French Pharmacopoeia
Introduced to Europe
17th century
Regulatory Status
French Pharmacopoeia, list A (stem bark and seed)
Ethnobotany & Traditional Use

History & Tradition

The tree was introduced to Europe in the 17th century as an ornamental. Seed flour was added to the oats of horses suffering from broken wind (“pousse”), which gave the plant its English name and its old French name, “châtaignier de cheval”.

In phytotherapy the seed is prepared as a mother tincture, a fluid or dry extract, or a standardized extract, and the stem bark and seed are both listed in the French Pharmacopoeia (list A).

Modern research has focused on escin and on clinical trials of seed extract in chronic venous insufficiency. 181516

⚠ Not From India

Despite the French name marronnier d'Inde, the tree comes from Asia Minor and northern Greece.

Timeline

Introduced to Europe

17th Century

Brought from Asia Minor and planted as an ornamental tree.

Feed for Horses

Traditional Use

Seed flour mixed with oats treated horses with broken wind.

Escin Characterized

1994 – 1997

The structures and activities of the escins Ia, Ib, IIa, IIb and IIIa are defined. 127

Cochrane Review

2012

Seed extract is reviewed for chronic venous insufficiency.

The Key Compounds

Escin — Deep Dive

The saponin mixture of the seed that underlies most of horse chestnut's pharmacology.

🧪

Escin (Total Saponins Up to 10%)

A mixture of triterpene saponins derived from protoescigenin and barringtogenol, reaching up to 45% in immature seeds, with five forms described: Ia, Ib, IIa, IIb and IIIa. 1

🔥

Anti-Inflammatory Escins

Escins Ia, Ib, IIa and IIb acted against acute inflammation in animal models. 7

🍷

Ethanol & Glucose Effects

The escins inhibited ethanol absorption and showed hypoglycemic activity in a glucose tolerance test. 1213

🧬

Coumarins of the Bark

Aesculoside (esculin) and its aglycones, fraxoside and scopoloside are found in the stem bark, together with flavonoids, tannins and allantoin. 3

Pharmaceutical Preparations

Parts Used & Available Forms

The seed is the main part used, with the stem bark and the buds as secondary sources.

Seed

The main part used, listed in the French Pharmacopoeia (list A).

Seed

Stem Bark

Also listed in the French Pharmacopoeia (list A); astringent and febrifuge in traditional use.

Bark

Buds & Young Shoots

Used in gemmotherapy as a venous circulatory tonic.

Gemmotherapy

Mother Tincture

Teinture-mère of the seed with its seed coat.

Liquid Extract

Fluid & Dry Extracts

Fluid extract, dry extract and the standardized EPS extract.

Extract

Intrait

A standardized dry alcoholic extract, stabilized by steaming after harvest, with 2% aescoside per 100 drops.

Standardized Extract

Clinical Dosimetry

Dosages

No standardized usual dosage has been established for horse chestnut; dosing should be guided by a qualified practitioner.

Phytochemistry

Composition

Constituents of the seed, and of the seed coat, stem bark and buds.

Seed (Cotyledon) — Primary Constituents

Saponins (Escin)Total saponins up to 10%, mainly escins Ia, Ib, IIa, IIb and IIIa 1
Major
Starch & LipidsStarch 40–50%, lipids 6–8%, polysaccharides and proteins 2
Present
Flavonoids & TanninsQuercetol, kaempferol and their glycosides, and trimeric (−)-epicatechin tannins
Present
Fixed Oil2–3%, with triterpenes, sterols, phospholipids, tocopherols and triglycerides (oleic and linoleic acids)
Present
Coumarins & Essential OilTraces of esculoside and fraxoside, and traces of essential oil
Present

Seed Coat, Bark & Buds

Seed CoatProanthocyanidols (including procyanidol B-2), aesculitanins and cinnamtanins
Present
Bark CoumarinsEsculoside and its aglycones (esculetol, 4-methylesculetol), fraxoside and scopoloside 3
Present
Bark Flavonoids & TanninsQuercitroside, quercetol, proanthocyanidins, epicatechin and allantoin 3
Present
Bud FlavonoidsFlavonol aglycones (rhamnocitrine, kaempferol, quercetin and myricetin derivatives) and flavan-3-ols 45
Present
Bud CarotenoidsViolaxanthin, neoxanthin, aesculaxanthin, lutein, β-carotene, β-cryptoxanthin and β-citraurine 6
Present

Plant Properties — Pharmacodynamics

Twelve pharmacodynamic properties are documented for horse chestnut, centered on venous tone and edema.

12 Properties Venotonic Anti-Edematous Clinical Reviews
🔥

Anti-Inflammatory

Escins reduced acute inflammation in animal models. 7

💧

Anti-Edematous & Anti-Exudative

Reduces tissue swelling and fluid exudation in inflammatory models. 7

🩸

Venous Tone & Vasoconstriction

Increases venous tone and has a venous vasoconstrictor effect, supported by clinical reviews. 89

🧪

Hyaluronidase Inhibition

The venotonic effect is attributed to inhibition of hyaluronidase by the saponins. 10

🛡️

Capillary Protection

Decreases capillary permeability and strengthens capillary resistance (no references given).

✨

Antioxidant

Antiradical and antioxidant in active-oxygen scavenging assays. 11

🍷

Reduced Ethanol Absorption

Escins inhibited ethanol absorption in animal studies. 1213

📉

Hypoglycemic

Escins lowered glucose in a glucose tolerance test. 1213

⚙️

Lysosomal & Adrenal Effects

Stimulates lysosomal enzymes; an increase in ACTH and corticoids is supposed but not established (no references given).

🪵

Astringent & Febrifuge

The bark of young stems is described as astringent and febrifuge in traditional use.

🌱

Venous Circulatory Tonic (Bud)

The bud is used in gemmotherapy as a venous tonic (no references given).

📋

Clinical Evidence in Venous Insufficiency

Seed extract has been assessed in a Cochrane review, a meta-analysis and a review of five clinical studies. 141516

Clinical Applications

Clinical Indications

Horse chestnut's best-documented use is venous insufficiency; other indications are mostly traditional.

🦵
Venous & Lymphatic Insufficiency
Primary Indication
  • Chronic Venous Insufficiency: seed extract has been assessed in a Cochrane review, a meta-analysis of randomized trials and a review of five clinical studies. 141516
  • Varicose Veins & Phlebitis: traditional indications of the whole plant.
  • Lymphatic Insufficiency: a traditional indication of the whole plant.
🩹
Hemorrhoids & Oral Mucosa
Traditional Indication
  • Hemorrhoids: including the hemorrhoidal attack.
  • Mouth Ulcers: aphthae and ulcerations of the oral mucosa.
🩺
Pelvic, Prostatic & Menstrual
Traditional Indication
  • Prostatic Hypertrophy: a traditional indication of the whole plant.
  • Pelvic Congestion: a traditional indication of the whole plant.
  • Dysmenorrhea: of circulatory origin.
🌱
Capillary Fragility & Gemmotherapy
Traditional Indication
  • Capillary Fragility: in combination with flavonoids, butcher's broom, local anesthetics and tocopherol.
  • Bud Preparations: varices, hemorrhoids, varicose ulcers and prostatic disorders.
Pharmacodynamics

Mode of Action

Horse chestnut acts mainly through escin, on venous tone, connective-tissue enzymes and inflammation.

🩸

Venous Tone

Seed extract increases venous tone and has a venous vasoconstrictor effect, which is the basis of its use in venous insufficiency. 89

🧪

Hyaluronidase Inhibition

Saponins from horse chestnut inhibit hyaluronidase and elastase, enzymes that break down connective-tissue components of the vessel wall, which is thought to contribute to the venotonic effect. 10

⚙️

Lysosomal Enzymes

The action of escin on lysosomal enzymes is a presumed mechanism and has not been fully established.

🔥

Anti-Inflammatory Action

Escins suppressed acute inflammation in animal models, supporting the anti-edematous and anti-exudative effects. 7

✨

Antioxidant Action

Plant extracts scavenge active oxygen species, contributing to the antiradical effect. 11

Clinical Safety

Safety & Interactions

Horse chestnut needs care with the kidneys, bleeding risk and anticoagulant or hypoglycemic medicines.

⚠️

Adverse Effects & Precautions

  • Kidney Toxicity: nephrotoxicity occurs at high doses, with no demonstrated risk in people with normal kidney function. 19202
  • Bleeding Risk: do not use before surgery.
  • Diabetes & Latex Allergy: use is advised against.
  • Pregnancy & Breastfeeding: avoid.
🚫

Contraindications & Interactions

  • Renal Insufficiency: contraindicated.
  • Anticoagulants: possible interaction, with an increased effect of warfarin reported. 1718
  • Hypoglycemic Drugs: possible interaction.
  • Regulatory Status: French Pharmacopoeia, list A, for the stem bark and seed.
Clinical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare provider before using horse chestnut, particularly if you take anticoagulant or diabetes medicines, have kidney disease, are pregnant or breastfeeding, or have surgery planned.
Common Questions

Frequently Asked Questions

What is horse chestnut used for?
Horse chestnut seed extract is used for venous and lymphatic insufficiency, varicose veins, phlebitis and hemorrhoids. Traditional uses also include prostatic hypertrophy, pelvic congestion, circulatory dysmenorrhea and mouth ulcers.
Does horse chestnut work for chronic venous insufficiency?
Horse chestnut seed extract has been assessed in a Cochrane review, in meta-analyses of randomized trials and observational studies, and in a review of five clinical studies of a fresh-plant seed extract. It is the best-documented use of the plant.
What is escin (aescin)?
Escin is the main saponin of horse chestnut seed. Total saponins reach up to 10% of the seed, and five forms are described (Ia, Ib, IIa, IIb and IIIa). Escins are associated with the anti-inflammatory, venotonic and hypoglycemic effects.
What is the usual horse chestnut dosage?
No standardized usual dosage has been established for horse chestnut; dosing should be guided by a qualified practitioner.
Is horse chestnut safe for the kidneys?
Nephrotoxicity has been reported at high doses, and horse chestnut is contraindicated in renal insufficiency. No risk was shown in people with normal kidney function in the studies cited on the source page.
Can horse chestnut be taken with warfarin?
Horse chestnut may interact with anticoagulants, and an increase in the effect of warfarin has been described. It should also not be used before surgery because of a bleeding risk.
Can pregnant women or diabetics use horse chestnut?
Horse chestnut should be avoided during pregnancy and breastfeeding, and in diabetes, because of possible interaction with hypoglycemic medicines. It is also advised against in latex allergy.
Is horse chestnut from India?
No. Despite the French name marronnier d'Inde, the tree comes from Asia Minor and northern Greece and reached Europe in the 17th century. The English name comes from the seed flour once added to oats for horses with broken wind.
Which part of horse chestnut is used?
The seed is the part used, and the stem bark is also listed in the French Pharmacopoeia (list A). Buds are used in gemmotherapy for varices, hemorrhoids and prostate disorders.
Sources

Bibliography

↑1. Yoshikawa M, Murakami T, Matsuda H, Yamahara J, Murakami N, Kitagawa I. Bioactive saponins and glycosides. III. Horse chestnut. (1): The structures, inhibitory effects on ethanol absorption, and hypoglycemic activity of escins Ia, Ib, IIa, IIb, and IIIa from the seeds of Aesculus hippocastanum L. Chem Pharm Bull (Tokyo). 1996;44(8):1454–1464.
PubMed: PMID 8795266 →
↑2. Vieu C. Le marronnier d'Inde (Aesculus hippocastanum L.): études botaniques, chimiques et thérapeutiques. Thèse de Sciences pharmaceutiques, Grenoble. 2014. dumas-01006873.
↑3. Becker LC, Bergfeld WF, Belsito DV, et al. Final report of the safety assessment of allantoin and its related complexes. Int J Toxicol. 2010;29(3 Suppl):84S–97S.
PubMed: PMID 20448269 →
↑4. Egger K, Wollenweber E, Tissut M. Free flavonol aglycones in the secretion of the buds of Aesculus spp. Z Pflanzenphysiol. 1970;62(5):464–466.
Abstract →
↑5. Feucht W, Treutter D. Flavan-3-ols in trichomes, pistils and phelloderm of some tree species. Ann Bot. 1990;65(2):225–230.
↑6. Deli J, Matus Z, Tóth G. Comparative study on the carotenoid composition in the buds and flowers of different Aesculus species. Chromatographia. 2000;51(1):S179–S182.
Full Text →
↑7. Matsuda H, Li Y, Murakami T, Ninomiya K, Yamahara J, Yoshikawa M. Effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biol Pharm Bull. 1997;20(10):1092–1095.
PubMed: PMID 9353571 →
↑8. Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Arch Dermatol. 1998;134(11):1356–1360.
PubMed: PMID 9828868 →
↑9. Suter A, Bommer S, Rechner J. Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: a review of 5 clinical studies. Adv Ther. 2006;23(1):179–190.
PubMed: PMID 16644618 →
↑10. Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch Pharm (Weinheim). 1995;328(10):720–724.
PubMed: PMID 8554461 →
↑11. Masaki H, Sakaki S, Atsumi T, Sakurai H. Active-oxygen scavenging activity of plant extracts. Biol Pharm Bull. 1995;18(1):162–166.
PubMed: PMID 7735233 →
↑12. Yoshikawa M, Harada E, Murakami T, et al. Escins-Ia, Ib, IIa, IIb, and IIIa, bioactive triterpene oligoglycosides from the seeds of Aesculus hippocastanum L.: their inhibitory effects on ethanol absorption and hypoglycemic activity on glucose tolerance test. Chem Pharm Bull (Tokyo). 1994;42(6):1357–1359.
PubMed: PMID 8069982 →
↑13. Yoshikawa M, Murakami T, Matsuda H, Yamahara J, Murakami N, Kitagawa I. Bioactive saponins and glycosides. III. Horse chestnut. (1): The structures, inhibitory effects on ethanol absorption, and hypoglycemic activity of escins Ia, Ib, IIa, IIb, and IIIa from the seeds of Aesculus hippocastanum L. Chem Pharm Bull (Tokyo). 1996;44(8):1454–1464. (Same study as reference 1, cited a second time in the original source.)
PubMed: PMID 8795266 →
↑14. Suter A, Bommer S, Rechner J. Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: a review of 5 clinical studies. Adv Ther. 2006;23(1):179–190. (Same study as reference 9, cited a second time in the original source.)
PubMed: PMID 16644618 →
↑15. Siebert U, Brach M, Sroczynski G, Berla K. Efficacy, routine effectiveness, and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency: a meta-analysis of randomized controlled trials and large observational studies. Int Angiol. 2002;21(4):305–315.
PubMed: PMID 12518108 →
↑16. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev. 2012;11:CD003230.
PubMed: PMID 23152216 →
↑17. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000;57(13):1221–1227.
PubMed: PMID 10902065 →
↑18. Argento A, Tiraferri E, Marzaloni M. Anticoagulanti orali e piante medicinali: una interazione emergente. Ann Ital Med Int. 2000;15(2):139–143. (Italian)
PubMed: PMID 10920504 →
↑19. Bastian HP, Valilensieck W. Nierenfunktion unter parenteraler Aescin-Behandlung. Med Klin. 1976;71:1295–1299.
↑20. Ascher PW. Renale Funktionsgrössen unter Na-Aescinat bei nierengesunden und nierenkranken Patienten. Therapiewoche. 1977;52:3–10.

Additional Sources

Bruneton J. Pharmacognosie, Phytochimie, Plantes médicinales. Éditions Tec & Doc. 1997; p. 555.
Vieu C. Le marronnier d'Inde (Aesculus hippocastanum L.): études botaniques, chimiques et thérapeutiques. Sciences pharmaceutiques. 2014. dumas-01006873. (Same work as reference 2, listed again in the original source.)